Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tridihexethyl. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 6/20 | 1.00 |
| ▸ | CHRM3 known ✓ | P20309 | 3/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 7/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 5/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.57 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.57 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.57 |
| ▸ | HRH1 | P35367 | 1/20 | 0.57 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.57 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.57 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.57 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.57 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | HTR1A | P08908 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tridihexethyl SCHEMBL2296006 | 1.00 | CHRM2 (1.00) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| Tridihexethyl SCHEMBL100471 | 0.99 | CHRM2 (0.97) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| Tridihexethyl SCHEMBL249851 | 0.99 | CHRM2 (0.97) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| SCHEMBL20045514 | 0.83 | CHRM2 (0.71) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| SCHEMBL9910958 | 0.81 | CHRM2 (0.68) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| SCHEMBL2933098 | 0.80 | CHRM2 (0.66) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| SCHEMBL12441787 | 0.80 | CHRM2 (0.66) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| Tridihexethyl SCHEMBL5824214 | 0.78 | CHRM2 (0.61) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| SCHEMBL10516359 | 0.77 | CHRM2 (0.64) | CHRM2CHRM1KCNH2CYP2D6CHRM3 | |
| SCHEMBL10392382 | 0.77 | CHRM2 (0.64) | CHRM2CHRM1KCNH2CYP2D6CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 791 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20250302814-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2025-10-02 | — | — | US | claimed |
| US-20250241933-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) | 2025-07-31 | — | — | US | claimed |
| EP-4543431-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) (US) | 2025-04-30 | — | — | EP | claimed |
| US-20240358709-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2024-10-31 | — | — | US | claimed |
| EP-3863708-B1 | MIXED IONIC CONDUCTORS AND CORRESPONDING DEVICES, SYSTEMS AND METHODS OF MAKING | BATTELLE MEMORIAL INSTITUTE (US) | 2024-09-11 | — | — | EP | claimed |
| US-20240261239-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2024-08-08 | — | — | US | claimed |
| EP-4395721-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) (US) | 2024-07-10 | — | — | EP | claimed |
| US-20240189328-A1 | COMBINATION OF NOREPINEPHRINE REUPTAKE INHIBITOR AND A CANNABINOID FOR USE IN TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2024-06-13 | — | — | US | claimed |
| US-20240189261-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2024-06-13 | — | — | US | claimed |
| US-6110972-A | ADMINISTERING THERAPEUTICALLY EFFECTIVE AMOUNT OF ENANTIOMERICALLY ENRICHED (S)-TRIDIHEXETHYL, OR ITS PHARMACEUTICALLY ACCEPTABLE SALT | SEPRACOR INC. (US) | 2000-08-29 | — | — | US | claimed |
| EP-0909170-A4 | METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERICALLY ENRICHED (S)-TRIDIHEXETHYL | SEPRACOR INC (US) | 2000-02-09 | — | — | EP | claimed |
| EP-0933992-A4 | METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERICALLY ENRICHED (R)-TRIDIHEXETHYL | SEPRACOR INC (US) | 2000-02-09 | — | — | EP | claimed |
| EP-0933992-A1 | METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERICALLY ENRICHED (R)-TRIDIHEXETHYL | SEPRACOR, INC. (US) | 1999-08-11 | — | — | EP | claimed |
| EP-0909170-A1 | METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERICALLY ENRICHED (S)-TRIDIHEXETHYL | SEPRACOR, INC. (US) | 1999-04-21 | — | — | EP | claimed |
| WO-1998000011-A1 | METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERICALLY ENRICHED (R)-TRIDIHEXETHYL | SEPRACOR, INC. (US) | 1998-01-08 | — | — | WO | claimed |
| WO-1998000122-A1 | METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERICALLY ENRICHED (S)-TRIDIHEXETHYL | SEPRACOR, INC. (US) | 1998-01-08 | — | — | WO | claimed |
| EP-0721348-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1996-07-17 | — | — | EP | claimed |
| WO-1995009006-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1995-04-06 | — | — | WO | claimed |
| US-4824676-A | ANTICHOLINERGIC AGENT TO SUPPRESS PERSPIRATION | SCHERING CORPORATION (US) | 1989-04-25 | — | — | US | claimed |